Inhibrx Biosciences
INBX
#5243
Rank
ยฃ1.19 B
Marketcap
ยฃ81.53
Share price
-6.47%
Change (1 day)
779.78%
Change (1 year)

Revenue for Inhibrx Biosciences (INBX)

Revenue in 2025 (TTM): ยฃ0.94 Million

According to Inhibrx Biosciences's latest financial reports the company's current revenue (TTM ) is ยฃ0.97 Million. an increase over the revenue in the year 2024 that were of ยฃ0.15 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inhibrx Biosciences from 2023 to 2025

Annual revenue

Year Revenue Change
2025 ยฃ0.96 M505.69%
2024 ยฃ0.15 M-87.44%
2023 ยฃ1.26 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA